To evaluate the correlation between USP14 and antitumor immunity in CRC, we performed multiplex immunofluorescence analysis using anti-keratin, anti-CD3, and anti-CD8 antibodies in CRC samples. The gene discussed is CD8A; the disease is colorectal carcinoma.